How do clinicians integrate oral octreotide into their treatment plan for acromegaly?

Lancet Diabetes Endocrinol. 2022 Feb;10(2):86-87. doi: 10.1016/S2213-8587(21)00319-3. Epub 2021 Dec 22.
No abstract available

Publication types

  • Comment

MeSH terms

  • Acromegaly* / drug therapy
  • Humans
  • Octreotide* / therapeutic use
  • Somatostatin

Substances

  • Somatostatin
  • Octreotide